Adriana Albini

Summary

Publications

  1. pmc Angiostatin anti-angiogenesis requires IL-12: the innate immune system as a key target
    Adriana Albini
    Polo Scientifico e Tecnologico, IRCCS Multimedica, Milan, Italy
    J Transl Med 7:5. 2009
  2. doi Angioprevention with fenretinide: targeting angiogenesis in prevention and therapeutic strategies
    Ilaria Sogno
    IRCCS Multimedica, Milan, Italy
    Crit Rev Oncol Hematol 75:2-14. 2010
  3. doi Mechanisms of Hyperforin as an anti-angiogenic angioprevention agent
    Girieca Lorusso
    IRCCS Multimedica, Responsabile Ricerca Oncologica, via Fantoli 16 15, 20138 Milan, Italy
    Eur J Cancer 45:1474-84. 2009
  4. pmc Effects of 5-fluorouracil on morphology, cell cycle, proliferation, apoptosis, autophagy and ROS production in endothelial cells and cardiomyocytes
    Chiara Focaccetti
    Science and Technology Center, IRCCS Multimedica, Milan, Italy
    PLoS ONE 10:e0115686. 2015
  5. doi Cardio-oncology in targeting the HER receptor family: the puzzle of different cardiotoxicities of HER2 inhibitors
    Adriana Albini
    Oncology Research Division, Polo Scientifico e Tecnologico IRCCS MultiMedica, Via Fantoli 16 15 20138, Milan, Italy
    Future Cardiol 7:693-704. 2011
  6. doi Inflammatory angiogenesis and the tumor microenvironment as targets for cancer therapy and prevention
    Antonino Bruno
    Polo Scientifico e Tecnologico, MultiMedica Onlus, Milano, Italy
    Cancer Treat Res 159:401-26. 2014
  7. ncbi The synthetic oleanane triterpenoid, CDDO-methyl ester, is a potent antiangiogenic agent
    Nicola Vannini
    Multimedica IRCCS, Milan, Italy
    Mol Cancer Ther 6:3139-46. 2007
  8. ncbi Anti-angiogenic properties of chemopreventive drugs: fenretinide as a prototype
    Ilaria Sogno
    IRCCS Multimedica, Oncology Research, Milan, Italy
    Recent Results Cancer Res 181:71-6. 2009
  9. doi Interactions of single-wall carbon nanotubes with endothelial cells
    Adriana Albini
    Polo Scientifico e Tecnologico, IRCCS Multimedica, Milano, Italy
    Nanomedicine 6:277-88. 2010
  10. doi Functional genomics of endothelial cells treated with anti-angiogenic or angiopreventive drugs
    Adriana Albini
    MultiMedica Castellanza VA and Oncology Research, IRCCS Multimedica, 20138 Milan, Italy
    Clin Exp Metastasis 27:419-39. 2010

Collaborators

Detail Information

Publications19

  1. pmc Angiostatin anti-angiogenesis requires IL-12: the innate immune system as a key target
    Adriana Albini
    Polo Scientifico e Tecnologico, IRCCS Multimedica, Milan, Italy
    J Transl Med 7:5. 2009
    ..Here we present evidence that IL-12, a principal TH1 cytokine with potent anti-angiogenic activity, is the mediator of angiostatin's activity...
  2. doi Angioprevention with fenretinide: targeting angiogenesis in prevention and therapeutic strategies
    Ilaria Sogno
    IRCCS Multimedica, Milan, Italy
    Crit Rev Oncol Hematol 75:2-14. 2010
    ....
  3. doi Mechanisms of Hyperforin as an anti-angiogenic angioprevention agent
    Girieca Lorusso
    IRCCS Multimedica, Responsabile Ricerca Oncologica, via Fantoli 16 15, 20138 Milan, Italy
    Eur J Cancer 45:1474-84. 2009
    ....
  4. pmc Effects of 5-fluorouracil on morphology, cell cycle, proliferation, apoptosis, autophagy and ROS production in endothelial cells and cardiomyocytes
    Chiara Focaccetti
    Science and Technology Center, IRCCS Multimedica, Milan, Italy
    PLoS ONE 10:e0115686. 2015
    ..Taken together, our data suggest that 5-FU can affect, both at the cellular and molecular levels, two key cell types of the cardiovascular system, potentially explaining some manifestations of 5-FU-induced cardiovascular toxicity. ..
  5. doi Cardio-oncology in targeting the HER receptor family: the puzzle of different cardiotoxicities of HER2 inhibitors
    Adriana Albini
    Oncology Research Division, Polo Scientifico e Tecnologico IRCCS MultiMedica, Via Fantoli 16 15 20138, Milan, Italy
    Future Cardiol 7:693-704. 2011
    ....
  6. doi Inflammatory angiogenesis and the tumor microenvironment as targets for cancer therapy and prevention
    Antonino Bruno
    Polo Scientifico e Tecnologico, MultiMedica Onlus, Milano, Italy
    Cancer Treat Res 159:401-26. 2014
    ..The considerations provided will be crucial for the design of new preventive approaches to the reduction in cancer risk that need to be applied to large populations composed of apparently healthy individuals...
  7. ncbi The synthetic oleanane triterpenoid, CDDO-methyl ester, is a potent antiangiogenic agent
    Nicola Vannini
    Multimedica IRCCS, Milan, Italy
    Mol Cancer Ther 6:3139-46. 2007
    ....
  8. ncbi Anti-angiogenic properties of chemopreventive drugs: fenretinide as a prototype
    Ilaria Sogno
    IRCCS Multimedica, Oncology Research, Milan, Italy
    Recent Results Cancer Res 181:71-6. 2009
    ....
  9. doi Interactions of single-wall carbon nanotubes with endothelial cells
    Adriana Albini
    Polo Scientifico e Tecnologico, IRCCS Multimedica, Milano, Italy
    Nanomedicine 6:277-88. 2010
    ..The implications on their biological activity must be taken into account when considering the use of these nanoparticles for therapeutic delivery of drugs...
  10. doi Functional genomics of endothelial cells treated with anti-angiogenic or angiopreventive drugs
    Adriana Albini
    MultiMedica Castellanza VA and Oncology Research, IRCCS Multimedica, 20138 Milan, Italy
    Clin Exp Metastasis 27:419-39. 2010
    ....
  11. doi Surface-activated chemical ionization-electrospray ionization source improves biomarker discovery with mass spectrometry
    Ilaria Sogno
    Science and Technology Pole, IRCCS Multimedica, Milan, Italy
    Rapid Commun Mass Spectrom 26:1213-8. 2012
    ..Therefore, more efficient ion-source technologies are needed to improve MS applications in biomarker discovery...
  12. ncbi Molecular pathways for cancer angioprevention
    Adriana Albini
    IRCCS Multimedica, Milan, Italy
    Clin Cancer Res 13:4320-5. 2007
    ..We highlight diverse mechanisms of action, implying that combination angioprevention approaches could further improve efficacy and be transferred to clinical practice...
  13. pmc Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention
    Adriana Albini
    Oncology Research Division, MultiMedica Castellanza VA, Milan, Italy
    J Natl Cancer Inst 102:14-25. 2010
    ..We also discuss mechanistic pathways and describe several potential protective agents that could be administered to patients with occult or overt risk for cardiovascular complications...
  14. pmc The tumor microenvironment of colorectal cancer: stromal TLR-4 expression as a potential prognostic marker
    Rosaria Cammarota
    Oncology Research Laboratory, Science and Technology Park, IRCCS Multimedica, via Fantoli 16 15, Milan, 20138, Italy
    J Transl Med 8:112. 2010
    ....
  15. ncbi Tumor microenvironment, a dangerous society leading to cancer metastasis. From mechanisms to therapy and prevention
    Adriana Albini
    IRCCS Multimedica Milano, Milan, Italy
    Cancer Metastasis Rev 27:3-4. 2008
    ....
  16. ncbi Metastasis signatures: genes regulating tumor-microenvironment interactions predict metastatic behavior
    Adriana Albini
    IRCCS Multimedica, Scientific and Technological Pole, via Fantoli 16 15, 20138, Milan, Italy
    Cancer Metastasis Rev 27:75-83. 2008
    ..Here we review these concepts and advance hypotheses on how gene expression of the primary tumor and the microenvironment can favor the spread of the metastasis seeds and how this knowledge can provide tools to secondary prevention...
  17. doi The 'chemoinvasion' assay, 25 years and still going strong: the use of reconstituted basement membranes to study cell invasion and angiogenesis
    Adriana Albini
    Polo Scientifico e Tecnologico, Casa di Cura MultiMedica IRCCS, Milan and Castellanza VA, Italy
    Curr Opin Cell Biol 22:677-89. 2010
    ..We review established applications and variants of the matrigel invasion assay, highlight key findings derived from it and discuss future developments, including roles for accessory and cancer stem cells...
  18. doi The biguanides metformin and phenformin inhibit angiogenesis, local and metastatic growth of breast cancer by targeting both neoplastic and microenvironment cells
    Stefania Orecchioni
    Laboratory of Hematology Oncology, European Institute of Oncology, Milan, Italy
    Int J Cancer 136:E534-44. 2015
    ....
  19. doi Diacylglycerol kinases are essential for hepatocyte growth factor-dependent proliferation and motility of Kaposi's sarcoma cells
    Gianluca Baldanzi
    Department of Experimental and Clinical Medicine, Universita del Piemonte Orientale Amedeo Avogadro, Novara IRCCS Multimedica, Milan, Italy
    Cancer Sci 102:1329-36. 2011
    ....